News New approach can help design shorter, more powerful trials to assess Parkinson’s drugs By November 10, 202258 views ShareTweet 0 Testing whether a new drug impacts the progression of Parkinson’s disease takes years, in part because the disease often advances so slowly.
Promising targeted therapy offers new hope to certain patients with advanced pancreatic cancer By 53 mins ago0
The epidemiology of COVID-19 outbreaks in farms in Ontario, Canada, in the pre-vaccine year of the pandemic 3 hours ago0
Is discontinuing universal SARS-CoV-2 testing at hospital admission in England and Scotland associated with increased hospital-onset infections? 4 hours ago0
By 
Comments